AGE - Contribution to the revision of the clinical trials directive

11 May 2011

AGE contributed to the consultation open by the European Commission on the revision of the clinical trials directive. Considering the recent development regarding geriatric medicines, particular the decision made by the European Medicine Agency (EMA) in February 2011 to launch a geriatric medicines strategy, AGE Platform Europe considered this revision of the directive has an opportunity to support this new strategy and decided to focus its contribution on the need to improve participation of older people in clinical trials of medicines commonly used for geriatric patients.

For more information, please click here

This website is developed with the financial support of operating grants of the European Commission.
The contents of the articles are the sole responsibility of AGE Platform Europe and can in no way be taken to reflect the views of the European Commission.